Krystal Biotech, Inc. KRYS Operating margin

Operating margin at other companies

Ultragenyx PharmaceuticalRARE

-73.6%-7.3pp

BridgeBio PharmaBBIO

-90.5%-41.2pp

Viridian Therapeutics, Inc.VRDN

-569.7%-284pp

RegenxbioRGNX

-94.1%-9.3pp

Zevra Therapeutics, Inc.ZVRA

-103.9%-43.0pp

BioCryst PharmaceuticalsBCRX

-33.3%-43.0pp

FAQ

What is Krystal Biotech, Inc.'s operating margin?

Krystal Biotech, Inc. (KRYS) reported operating margin of 42.8% in Q1 2026.

How has Krystal Biotech, Inc.'s operating margin changed year-over-year?

Krystal Biotech, Inc.'s operating margin increased by 31.4% year-over-year, from 32.6% to 42.8%.

What is the long-term trend for Krystal Biotech, Inc.'s operating margin?

Over 2 years (2023 to 2025), Krystal Biotech, Inc.'s operating margin has grown at a -56.9% compound annual growth rate (CAGR), from -222.6% to 41.4%.

What does operating margin mean?

Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.